why choose us

First received: June 07, 2023

Clinical Trial: Pan-Malaria Transmission-Blocking Vaccine AnAPN1

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Malaria

Study Type: INTERVENTIONAL


Official Title: A Randomized Double-blinded Phase 1 Clinical Trial to Assess Safety, Tolerability and Reactogenicity of the Pan-Malaria Transmission-Blocking Vaccine AnAPN1 in Healthy Adults Living in Gabon

Brief Summary: Malaria is still responsible for more than 627,000 deaths each year, predominantly among children under 5 years old.Current reductions in deaths have stagnated, and additional setbacks for malaria control programs due to the Coronavirus Disease 2019 (COVID-19) pandemic are expected.To achieve malaria elimination and eradication a leverage concerted approaches to reduce clinical disease and prevent new infections is a must.The existing malaria controls tools including the a recombinant protein-based malaria vaccine…

Read more